Advertisement
Home »

Most Patients With Eosinophilic Asthma on Benralizumab Can Successfully Taper Inhaled Corticosteroids

Sep 26, 2023

REFERENCES & ADDITIONAL READING

Jackson D. Late Breaking Abstract – SHAMAL: reduction of maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab: a randomised phase 4 study. Presentation 798, ERS International Congress 2023, 9-13 September, Milan, Italy.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement